CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Huaren Pharmaceutical Co Ltd Company Snapshot
Huaren Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Huaren Pharmaceutical Co Ltd with three other companies in this sector in China: Hebei Changshan Biochemical Pharmaceutical Co Ltd (2017 sales of 1.42 billion Chinese Renmimbi [US$204.16 million] of which 100% was Biomedicine), Porton Pharma Solutions Ltd (1.18 billion Chinese Renmimbi [US$170.22 million] of which 83% was Pharmaceutical R&D Production), and Asymchem Laboratories Tian Jin Co Ltd (1.42 billion Chinese Renmimbi [US$204.58 million] of which 100% was Pharmaceutical industry).

Sales Analysis. During the year ended December of 2017, sales at Huaren Pharmaceutical Co Ltd were 1.31 billion Chinese Renmimbi (US$188.60 million). This is an increase of 5.0% versus 2016, when the company's sales were 1.25 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Huaren Pharmaceutical Co Ltd (and since 2012, sales have increased a total of 133%). Sales of Medicine Industry saw an increase that was more than double the company's growth rate: sales were up 16.8% in 2017, from 1.00 billion Chinese Renmimbi to 1.17 billion Chinese Renmimbi. Not all segments of Huaren Pharmaceutical Co Ltd experienced an increase in sales in 2017: sales of Medicine Commerce fell 42.3% to 143.54 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Huaren Pharmaceutical Co Ltd
  Stock Performance Chart for Huaren Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/9/2018): 3.41
(Figures in Chinese Renmimbi)
1 Week 2.4%   13 Weeks -20.1%  
4 Weeks -27.4%   52 Weeks -69.8%  
 
Huaren Pharmaceutical Co Ltd Key Data:
  Ticker: 300110 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 1,311,875,366
(Year Ending Jan 2018).
Employees: 2,639
  Currency: Chinese Renmimbi Market Cap: 4,031,346,269
  Fiscal Yr Ends: December Shares Outstanding: 1,182,212,982
  Share Type: A gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.